Spectrum Oncology Private Limited, a under liquidation private limited company, was established on 01 May 2008 in Mumbai, Maharashtra, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U51397MH2008PTC181835. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.19 M.
Formerly known as Oncorx Pharma Private Limited. It upholds a compliant status. Its leadership includes Arun Shankar Nanivadekar (Director), Hemanshu Lalitbhai Kapadia (Irp/Rp/Liquidator), Purvish Mahendra Parikh (Director). Past directors included Agya Singh Kochar, Arun Shankar Nanivadekar, Bhavana Sharadchandra Doshi. Its latest AGM occurred on 05 July 2023, with the balance sheet filed on 31 March 2023. It is based at Ofc No 1 Sadhana Bldg Gr Flr 207, David Barreto Rd Opp Wadala Stn Wadala West, Mumbai, Maharashtra, 400031.
U51397MH2008PTC181835
181835
01 May 2008
₹1.00 M
₹0.19 M
Roc Mumbai
Unlisted
Under Liquidation
Explore comprehensive insights into Spectrum Oncology Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Arun Shankar Nanivadekar | Director | 30 Jun 2009 | Current |
| Hemanshu Lalitbhai Kapadia | Irp/Rp/Liquidator | 09 May 2024 | Current |
| Purvish Mahendra Parikh | Director | 30 Jun 2009 | Current |
| Satyanarain Rameshwardas Agarwala | Director | 01 May 2008 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 21 Dec 2012 | Past |
| Pramod Abcsdd | Director Appointed In Casual Vacancy | 30 Sep 2009 | Past |
| Pramod Abcsdd | Director | 20 Jan 2009 | Past |
| Pramod Abcsdd | Director | 20 Jan 2009 | Past |
| Pramod Abcsdd | Director | 28 Sep 2012 | Past |
| Pramod Abcsdd | Director | 04 Jan 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Spectrum Oncology Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 14.03% increase. The company also saw a slight improvement in profitability, with a 6.09% increase in profit. The company's net worth observed a substantial decline by a decrease of 11.99%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Spectrum Oncology had a promoter holding of 99.99% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Spectrum Oncology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Spectrum Oncology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spectrum Oncology's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Hemanshu Lalitbhai Kapadia was appointed as a IRP/RP/Liquidator was appointed as a IRP/RP/Liquidator on 09 May 2024 & has been associated with this company since 1 year 8 months . was documented.
Progress on Spectrum Oncology Private Limited last Annual general meeting of members was held on 05 Jul 2023 as per latest MCA records. was documented.
The activity Spectrum Oncology Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai. was completed.
Arun Shankar Nanivadekar was appointed as a Director was appointed as a Director on 30 Jun 2009 & has been associated with this company since 16 years 6 months . was recorded as a recent event.
Progress on Purvish Mahendra Parikh was appointed as a Director was appointed as a Director on 30 Jun 2009 & has been associated with this company since 16 years 6 months . was documented.
Satyanarain Rameshwardas Agarwala was appointed as a Director was appointed as a Director on 01 May 2008 & has been associated with this company since 17 years 8 months . was recorded as a recent event.
The CIN of Spectrum Oncology Private Limited is U51397MH2008PTC181835.
Spectrum Oncology Private Limited is headquartered at Ofc No 1 Sadhana Bldg Gr Flr 207, David Barreto Rd Opp Wadala Stn Wadala West, Mumbai, Maharashtra, 400031.
Spectrum Oncology Private Limited was incorporated on 01 May 2008.
The current directors of Spectrum Oncology Private Limited are
The primary industry of Spectrum Oncology Private Limited is Professional, Scientific And Technical.
Spectrum Oncology Private Limited is unlisted.
The authorized capital of Spectrum Oncology Private Limited is ₹1.00 M, and the paid-up capital is ₹0.19 M.
The compliance status of Spectrum Oncology Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX